Daniel Keizman

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

Daniel Keizman, Maya Ish‐Shalom, Peng Huang et al. · European Journal of Cancer · 2011 · 208 citations

Urology, Pre-treatment Neutrophil, Genitourinary Cancer +6

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park et al. · The Lancet Oncology · 2022 · 162 citations · Full text

Urology, Oncology, Metastatic Urothelial Carcinoma +7

Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?

Daniel Keizman, Maya Ish‐Shalom, Shlomo Berliner et al. · Journal of the Neurological Sciences · 2009 · 138 citations

Electrolyte Disorder, Amyotrophic Lateral Sclerosis, Physiology +4

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination

Daniel Keizman, Peng Huang, Mario A. Eisenberger et al. · European Journal of Cancer · 2011 · 128 citations

Urology, Oncology, Genitourinary Cancer +8

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis

Daniel Keizman, Ori Rogowski, Shlomo Berliner et al. · Acta Neurologica Scandinavica · 2009 · 109 citations